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In many gram negative bacilli, AmpD plays a key role in both cell well-recycling
pathway and β-lactamase regulation, inactivation of the ampD causes the accumulation
of 1,6-anhydromuropeptides, and results in the ampC overproduction. In Yersinia
enterocolitica, the regulation of ampC expression may also rely on the ampR-ampC
system, the role of AmpD in this species is still unknown. In this study, three AmpD
homologs (AmpD1, AmpD2, and AmpD3) have been identified in complete sequence
of strain Y. enterocolitica subsp. palearctica 105.5R(r). To understand the role of three
AmpD homologs, several mutant strains were constructed and analyzed where a rare
ampC regulation mechanism was observed: low-effective ampD2 and ampD3 cooperate
with the high-effective ampD1 in the three levels regulation of ampC expression.
Enterobacteriaceae was used to be supposed to regulate ampC expression by two
steps, three steps regulation was only observed in Pseudomonas aeruginosa. In this
study, we first reported that Enterobacteriaceae Y. enterocolitica can also possess a three
steps stepwise regulation mechanism, regulating the ampC expression precisely.
Keywords: Yersinia enterocolitica, AmpC β-lactamase, AmpD, synergy effect, antimicrobial resistance
INTRODUCTION
Yersinia enterocolitica is a human enteric pathogen with worldwide distribution. It is a highly
heterogeneous species with six biovars (1A, 1B, 2, 3, 4, and 5) that has more than fifty serotypes with
different geographical distribution, ecological niches, and pathogenic properties (Wang et al., 2009;
Liang et al., 2012). Most Y. enterocolitica strains produce two kinds of chromosomal β-lactamases,
BlaA (a non-inducible broad-spectrum carbenicillinase) and BlaB (an AmpC-type inducible group
I class C cephalosporinase; Cornelis and Abraham, 1975). A recent study shows in 1B/O:8 strain
8081, the expression of BlaA is constitutive whereas the AmpC (BlaB) was inducible (Bent and
Young, 2010). Meanwhile, the two β-lactamases are not expressed simultaneously in all strains
because strains with different biotypes tend to display specific resistance phenotypes (Stock et al.,
2000). The mechanism of variable expression and activities of these two β-lactamases is unknown
(De La Prieta et al., 1995, 2006; Stock et al., 1999; Pham et al., 2000; Sharma et al., 2006).
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Chromosomal cephalosporinase AmpC is ubiquitous in
Gram-negative organisms (Jacoby, 2009). Most strains express
the AmpC β-lactamase constitutively at a low basal level and
expression is high in induced conditions. The regulation of
ampC expression is controlled by several regulatory genes,
e.g., ampR, ampG, and ampD, which belong to the ampR-
ampC system as part of the cell-wall recycling pathway (Park
and Uehara, 2008). Bacterial peptidoglycan is remodeled in a
dynamic balance between synthesis and degradation. During
growth, the peptidoglycan in the periplasm is hydrolyzed by
murein hydrolases to generate peptidoglycan (PG) degradation
products (GlcNAc-1,6-anhydro-MurNAc; Johnson et al., 2013).
The products are transported to the cytosol via an inner
membrane permease, AmpG (Cheng and Park, 2002; Park
and Uehara, 2008; Johnson et al., 2013), playing roles for
cell wall precursors (Park and Uehara, 2008) and signaling
molecules for the induction of β-lactamase (Jacobs et al.,
1994; Hanson and Sanders, 1999). AmpD is a cytoplasmic
N-acetyl-anhydromuramyl-L-alanine amidase, which has been
well-studied in Enterocobacter cloacae, Citrobacter freundii, and
Pseudomonas aeruginosa. GlcNAc-1,6-anhydromuropeptide and
1,6-anhydromuropeptide are hydrolyzed by AmpD to generate
1,6-anhydromuramic acid and peptide where the peptide is
reused by enzymes in the cell wall recycling pathway to generate
UDP-MurNAc-pentapeptide that binds to the transcriptional
regulator AmpR allosterically to repress ampC expression
(Lindberg et al., 1987; Holtje et al., 1994; Jacobs et al.,
1997).
Inactivation of AmpD is themajor cause of constitutive hyper-
production of AmpC giving high β-lactam resistant phenotypes
(Peter et al., 1988; Jacobs et al., 1995). In a recent study, Juan et al.
demonstrated a stepwise upregulation mechanism with three
AmpD homologs termed AmpD, AmpDh2, and AmpDh3; a
highly sophisticated regulation mechanism for ampC expression
in P. aeruginosa PAO1, the first characterized example in a
multiple-step sequential regulation of β-lactamase expression in
Gram-negative bacteria (Juan et al., 2006). Further, after the
discovery of AmpD-like lipoprotein, AmiD, in Escherichia coli
(Kerff et al., 2010), Enterobacteriaceae were thought to have
ampD homologs (Juan et al., 2006; Yang et al., 2009), regulating
ampC expression in two steps, however, there is no structural data
are available. Y. enterocolitica was supposed to regulate ampC
expression by ampC-ampR system because the presents of ampC-
ampR region in chromosome (Seoane et al., 1992), but the feature
of ampC regulation in Y. enterocolitica is still a mistiness. In the
present study, we found Y. enterocolitica strain subsp. palearctica
105.5R(r) had three putative ampD homologs. This suggested
Y. enterocolitica possessed a complex regulation mechanism for
β-lactamase expression.
MATERIALS AND METHODS
Bacterial Strains and Growth Conditions
The bacterial strains used in this study were listed in Table 1.
The wild-type Y. enterocolitica strain subsp. palearctica 105.5R(r)
(bioserotype 3/O:9) chromosome was completely sequenced as
described in our previous work (Wang et al., 2011). Strains
were routinely grown in Luria Bertani (LB) broth or on LB
plates at 28◦C (Y. enterocolitica) and 37◦C (E. coli). When
appropriate, antibiotics were added to the media as required to
a final concentration of 34 µg/ml for chloramphenicol (Cm) and
5 µg/ml for tetracycline (Tc). Yersinia selective supplement was
added to the solid LB medium as suggested by the manufacturer
(Oxoid, UK).
Construction of ampD1, ampD2, and ampD3 Mutant
Strains
After a homology search, we identified three potential Y.
enterocolitica ampD homologs termed ampD1, ampD2, and
ampD3. To further study them, three ampD single (YE1D1,
YE1D2, YE1D3), three double (YE1D1D2, YE1D1D3,
YE1D2D3), and one triple (YE1D1D2D3) mutants were
constructed using the following steps. Briefly, to three single
ampD mutant strains, two PCR amplicons (Table 2) upstream
and downstream of ampD1, ampD2, and ampD3 were cloned
into the suicide plasmid, pDS132 (Philippe et al., 2004),
using restriction with SphI and SacI with the in-fusion
cloning technique to obtain plasmids pDSD1, pDSD2, pDSD3.
Recombinant plasmids were then transformed into E. coli DH5α
and transformed into the helper strain, S17 λpir (Simon et al.,
1983); and selected on 34 µg/ml chloramphenicol LB agar plates.
Using conjugation, recombinant plasmids were introduced into
Y. enterocolitica 105.5R(r); and transconjugants were selected
using LB plates with 34 µg/ml chloramphenicol in Yersinia
selective agar medium (Oxoid) and then incubated on LB plates
without antibiotic overnight. For mutant selection, bacterial
cultures were transferred onto LB plates containing 10% sucrose
without NaCl. The mutants were confirmed using antibiotic
resistance, PCR amplification, and sequencing. The double
mutants and triple mutant strains were then constructed from
the single mutants sequentially using the same procedures.
Antibiotic Susceptibility Testing
The minimum inhibitory concentrations (MICs) of 15
antibiotics were determined in triplicate using the standard
2-fold serial broth microdilution method according to the
guidelines of the Clinical Laboratory Standards Institute
(CLSI, 2015) for ampicillin, ticarcillin, cefazolin, piperacillin,
ceftazidime, cefriaxone, cefepime, piperacillin/tazobactam,
ampicillin/sulbactam, cefoxitin, cefotetan, aztreonam, imipenem,
meropenem, and ciprofloxacin. Escherichia coli ATCC 25922 was
used as a control strain in each assay.
Measurement the Expression of blaA and
ampC using luxCDABE Reporter System
The expression levels of blaA and ampC were determined
using the luxCDABE reporter system. Primers pPampC-F,
pPampC-R were used to amplify the ampC promoter region
fragment, respectively; and was cloned into the plasmid pBBRLux
(Hammer and Bassler, 2007) which carried promoter-less
luxCDABE genes to generate the fusion plasmid pLUXampC.
The resulting plasmid was then introduced into E. coli S17 λpir
and finally transferred into the wild-type strain 105.5R(r) and
the seven derivate ampD mutants with or without cefoxitin.
Frontiers in Microbiology | www.frontiersin.org 2 August 2016 | Volume 7 | Article 1282
Liu et al. AmpD Homologs of Yersinia enterocolitica
TABLE 1 | Strains and plasmids used in this study.
Strains or plasmid Genotype or relevant characteristics Source or References
Yersinia enterocolitica
105.5R(r) Wild type; completely sequenced Wang et al., 2011
YE1D1 105.5R(r) 1ampD1 This work
YE1D2 105.5R(r) 1ampD2 This work
YE1D3 105.5R(r) 1ampD3 This work
YE1D1D2 105.5R(r) 1ampD1 1ampD2 This work
YE1D1D3 105.5R(r) 1ampD1 1ampD3 This work
YE1D2D3 105.5R(r) 1ampD2 1ampD3 This work
YE1D1D2D3 105.5R(r) 1ampD1 1ampD2 1ampD3 This work
105.5R(r)-ampCLux 105.5R(r) containing plasmid pBBR-ampC-Lux This work
YE1D1-ampCLux YE1D1 containing plasmid pBBR-ampC-Lux This work
YE1D2-ampCLux YE1D2 containing plasmid pBBR-ampC-Lux This work
YE1D3-ampCLux YE1D3 containing plasmid pBBR-ampC-Lux This work
YE1D1D2-ampCLux YE1D1D2 containing plasmid pBBR-ampC-Lux This work
YE1D1D3-ampCLux YE1D1D3 containing plasmid pBBR-ampC-Lux This work
YE1D2D3-ampCLux YE1D2D3 containing plasmid pBBR-ampC-Lux This work
YE1D1D2D3-ampCLux YE1D1D2D3 containing plasmid pBBR-ampC-Lux This work
E. coli
DH5α F-endA1 hsdR17 (rk−, mk+) supE44 thi-1 λ-recA1 gyrA96 relA1 deoR 1(lacZYA-argF)-U169 80dlacZ1M15 Invitrogen
S17 λpir λ-pir R6K(thi thr leu ton lacY supE recA::RP4-2Tc::Mu) Simon et al., 1983
PLASMIDS
pDS132 CmR; Conditionally replicating vector; R6K origin, mobRK4 transfer origin, sucrose-inducible sacB Philippe et al., 2004
pDSD1 CmR; pDS132 containing 5′ and 3′ flanking sequence of ampD1 This work
pDSD2 CmR; pDS132 containing 5′ and 3′ flanking sequence of ampD2 This work
pDSD3 CmR; pDS132 containing 5′ and 3′ flanking sequence of ampD3 This work
pBBRLux CmR; Luminescence without promoter (or contains a promoterless luxCDABE reporter) Zhou et al., 2013
pLUXampC CmR; pBBRlux containing 250 bp 5′ flanking sequence of ampC This work
pSRKTcD1 TcR; pSRKTc containing 105.5R(r) ampD1 gene This work
pSRKTcD2 TcR; pSRKTc containing 105.5R(r) ampD2 gene This work
pSRKTcD3 TcR; pSRKTc containing 105.5R(r) ampD3 gene This work
The inducibility of BlaA and AmpC β-lactamase was confirmed.
Overnight cultures were diluted 1:100 into 15 ml LB broth and
incubated with shaking at 28◦C until mid-log phase was attained,
then the cultures were incubated with the presence of 1/4- to 10-
fold of MIC-values of imipenem and cefoxitin for an additional
1 h before harvesting. Luminescence was measured using an
InfiniteM200 Pro spectrophotometer and calculated with relative
light units. Mean luminescence/OD600-values were obtained in
three independent experiments (Zhou et al., 2013).
Quantification of β-Lactamase Activity
β-Lactamase specific activity was determined
spectrophotometrically in crude sonic extracts from strain
105.5R(r) and the seven above-described ampD mutants. To
determine the β-lactamase specific activity after induction,
the cultures were incubated in the presence of 40 µg/ml
cefoxitin for 1 h before harvesting. The samples were centrifuged
for 5 min at 3000 × g and the pellets were washed once
in 5 ml 0.01 M phosphate buffered saline, pH 7.0 and re-
suspended in 1 ml of the same buffer. The suspensions were
sonicated on ice for 3 min, and then centrifuged at 10,000 ×
g for 30 min at 4◦C and the supernatant was retained. After
determining the total protein using Bio-Rad protein assay
reagents, 10 min reactions were allowed before nitrocefin
hydrolysis was measured. The specific activity (U/mg) was
calculated as nanomoles of nitrocefin hydrolyzed per minute
per milligram of protein, using an extinction coefficient (1ε)
of 20,500 M−1 cm−1 for nitrocefin at 486 nm, as suggested by
the manufacturer (Oxoid, UK; Kong et al., 2005). The mean
β-lactamase activity obtained in three independent experiments
was analyzed.
Complementation Assay
In the complementation assay, the ORFs of ampD1, ampD2, and
ampD3 were amplified and cloned into the broad-host-range
expression vector, pSRKTc, to generate pSRKTcD1, pSRKTcD2,
and pSRKTcD3, respectively. The three recombinant plasmids
and plasmid pSRKTc (as a control) were transferred into the
completely de-repressed strain YE1D1D2D3. Transformants
were selected on 5 µg/ml tetracycline Yersinia selective plates.
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TABLE 2 | Primers used in this work.
Primer Sequence (5′–3′) PCR product size (bp) Use
p1ampD1U-F GAGGTACCGCATGGCCTGTTTCAGCATAGTTGC 952 ampD1 inactivation
p1ampD1U-R ACAAAGTGACAAACTATACGTTACCTAAGCCCCCTAACCT
p1ampD1D-F AGGTTAGGGGGCTTAGGTAACGTATAGTTTGTCACTTTGT 945
p1ampD1D-R GAATTCCCGGGAGGCACCATAAATAGTCAGTAA
p1ampD2U-F GAGGTACCGCATGTACAAGCATTGGGTGAAGAA 975 ampD2 inactivation
p1ampD2U-R TTAAATAACTTTTACCGCGCAAGCACAGTTATAGTGAACC
p1ampD2D-F GGTTCACTATAACTGTGCTTGCGCGGTAAAAGTTATTTAA 992
p1ampD2D-R GAATTCCCGGGAGGTAACTGACCTGACCGTTCC
p1ampD3U-F GAGGTACCGCATGTTTATCGACACTCACAACTA 954 ampD3 inactivation
p1ampD3U-R TGGCGGCGCTGTATCTAGTCTAATGTTATTTATTGAGGAT
p1ampD3D-F ATCCTCAATAAATAACATTAGACTAGATACAGCGCCGCCA 945
p1ampD3D-R GAATTCCCGGGAGGTATCAGCCAATCACCAATG
pPampC-F CGAGCTCGCGTATCCGCGATAC 384 ampC promoter activity
pPampC-R CGGATCCTAGTAAATCTTCCAT
pCampD1-F CCATATGATGCAGTTAGAAAATAACTG 576 ampD1 complementation
pCampD1-R CGAGCTCTTACGATGGTAAAGATGACT
pCampD2-F CCATATGATGAGGAAGTTATTAAGCAC 852 ampD2 complementation
pCampD2-R CGAGCTCTCAAGGATGAAGGGGACGAT
pCampD3-F CCATATGATGTATATGATTGACTATAA 777 ampD3 complementation
pCampD3-R CGAGCTCCTAGTTCTGTGCCGGAAAAT
Restriction enzyme recognition sites are underlined.
Finally, β-lactamase activity was determined to evaluate the
function of each AmpD homolog.
RESULTS
Yersinia enterocolitica subsp. Palearctica
105.5R(r) Has Three AmpD Homologs
As shown in Figure 1, the predicted amino acid sequences
of AmpD were screened using ClustalW software multiple
sequence alignment of AmpD1 (accession no. WP_005156822),
Y. enteoroclitica AmpD2 (accession no. WP_005164953),
AmpD3 (accession no. WP_013649890), and other closely
related bacterial strains e.g., the AmpD from the E. coli K-12
(accession no. AAC73221), AmpD of C. freundiiOS60 (accession
no. Z14002), AmpD of E. cloacae ATCC13047 (accession
no. CAA78391) and the AmpD (accession no. NP_253211),
AmpDh2 (accession no. NP_254172), and AmpDh3 (accession
no. NP_249498) of P. aeruginosa PAO1. The predicted amino
acid sequence for the AmpD1 protein exhibited 76.4, 76.1,
76.7, and 70% identity to the AmpD of E. coli K-12, C. freundii
OS60, E. cloacae ATCC13047, and P. aeruginosa, respectively.
Further, AmpD2 (AmpD3) exhibited 44.9% (38%) and 44.8%
(65.2%) identity to P. aeruginosa AmpDh2 and AmpDh3,
respectively. All three AmpD homologs in Y. enterocolitica
have four common residues at positions 34(H), 69(H), 154(H),
and 165(P) shown by Jacobs et al. (1995); and six essential
residues 34(H), 116(E), and 154(H), 162(K), 164(D) for C.
freundii AmpD activity reported by Genereux et al. were also
found (Genereux et al., 2004). The Amino acid phylogenetic
trees of AmpD formed two branches: branch A contained
Y. enterocolitica AmpD1 and all other “traditional” AmpD
from different strains; branch B contained AmpD2, AmpD3
from Y. enterocolitica and AmpDh2 and AmpDh3 from P.
aeruginosa PAO1 (Figure 2). Distribution of the three AmpD
homologs in Y. enterocolitica was different. Using the DNA
BLAST program provided by NCBI, we found the ampD1 and
ampD2 were widely distributed in the Y. enterocolitica strains
including 8081 (O:8), WA (O:8), Y11 (O:9), W22703 (O:9),
Y53/03(O:5), and even in the atypical strain LC20. However,
only three Y. enterocolitica strains (2015-87, W22703, Y11) and
105.5R(r) have ampD3 genes among the available uploaded
DNA sequences. According to the SignalP4.1 Server prediction
(Petersen et al., 2011), the AmpD1 and AmpD3 protein is likely
a cytoplasmic protein, AmpD2 is likely a secretory protein with
signal peptide sequence.
AmpD1, AmpD2, and AmpD3 Are Negative
Regulators of ampC Expression at
Different Levels
As shown in Figure 3A, we confirmed the best inducer of the
induction assay was cefoxitin (40 mg/L). Figure 3B showed
inactivation of the ampD homologs caused three different
levels of enhancements in ampC expression. At level one,
mutant strains YE1D2 (ampD2 inactivation), YE1D3 (ampD3
inactivation), and the double mutant strain YE1D2D3 (ampD2-
ampD3 double inactivation) only slightly increased ampC
promoter activity. At level two, luminescence values showed an
obvious elevation when the ampD1 inactivated strain, YE1D1,
was examined; and hence, the ampC promoter activity of double
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FIGURE 1 | Amino acid sequence alignment of AmpD homologs of different Gram-negative bacteria using ClustalW. AmpD-E.col (E. coli K-12 accession
no. AAC73221), AmpD-C.fre (C. freundii OS60 accession no. Z14002), AmpD-E.clo (E. cloacae accession no. CAA78391), AmpD-P.aer (P. aeruginosa PAO1
accession no. NP_253211), AmpDh2-P.aer (P. aeruginosa PAO1 accession no. NP_254172), AmpDh3-P.aer (P. aeruginosa PAO1 accession no. NP_249498),
AmpD1-Y.ent (Y. enterocolitica accession no. WP_005156822), AmpD2-Y.ent (Y. enterocolitica 105.5R accession no. WP_005164953) and AmpD3-Y.ent (Y.
enterocolitica 105.5R accession no. WP_013649890) are shown. Asterisk, colons, and periods represent identical, conserved, and semi-conserved residues,
respectively. The conserved and essential amino acids for AmpD activity are indicated in bold.
FIGURE 2 | Amino acid sequence phylogenetic analysis of AmpD
homologs from different Gram-negative bacteria. Y. enterocolitica
AmpD1 belong to the branch A with the other “traditional” AmpD, Y.
enterocolitica AmpD2 and AmpD3 belong to the second branch with P.
aeruginosa AmpDh2 and AmpDh3 discovered recently.
mutant strain YE1D1D2 was further enhanced. Finally, at level
three, in ampD1–ampD3 relative double/triple mutant strains,
YE1D1D3 and YE1D1D2D3, ampC promoter activity was
dramatically increased in both basal and induced conditions.
But the activity was elevated only at modest level under the
inducible conditions. At the same time, not surprisingly, neither
any mutation nor inducer change the BlaA expression (data not
shown).
Role of AmpD1, AmpD2, and AmpD3 in
β-Lactamase Activity and β-Lactam
Resistance in Y. enterocolitica
To further understand the role of AmpD homologs in
Y. enterocolitica, we tested the β-lactamase activity and the
minimal inhibitory concentrations (MICs) of 15 antibiotics in
the eight test strains mentioned above. As shown in Figure 4A,
the value of β-lactamase activity in wild-type strain with or
wothout inducer was consist with the biotype 3 strain reported
by Stock et al. (2000). On the ampD mutant aspect, the levels
of β-lactamase activity was consistent with luminescence values,
three β-lactamase activity levels occur. At level one, β-lactamase
activity of mutant strains YE1D2 (p < 0.05), YE1D2D3 (p
< 0.05), and YE1D3 (no statistically significant) was only
slightly increased compared with the wild-type strain 105.5R(r)
(∼1.2- to 3-fold), whereas a modest level increase appeared
in strain YE1D1 (p < 0.05) and YE1D1D2 (p < 0.05; ∼10-
to 20-fold) compared to at level two. Finally, at level three,
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FIGURE 3 | Induction assay by monitor the ampC promoter activity of Y. enterocolitica 105.5R(r) to choose an appropriate inducer (A), each group was
added in IMP or FOX by 0.125-, 1-, 2-, 5-, 10-fold MIC-value, respectively. Then the activity of ampC promoter of 105.5R(r) and its seven derived mutants were
tested (B), the strains were grown in the 40 mg/L Cefoxitin for 1 h. Error bars indicate standard deviations for triplicate experiments.
FIGURE 4 | Three AmpD homologs cooperate to regulate the ampC expression in Y. enterocolitica in eight test strains. (A) Inactivation of AmpD
homologs causes the elevation on β-lactamase activity in variant degree. (B) In complementation assay, hyperproduction of single AmpD1 (pSRKTcD1) and AmpD2
(pSRKTcD2) in YE1D1D2D3 will reduce the β-lactamase activity into wild-type strain levels, however, single AmpD3 (pSRKTcD3) do not possess full capacity as
AmpD1 and AmpD3. This data are the average of the measurements made in triplicate, the error bars indicate standard deviations.
complete derepression was reached in YE1D1D3 (p< 0.05) and
YE1D1D2D3 (p < 0.05) where the β-lactamase activity of these
two strains were significantly increased (∼38-fold) compared to
YE105.5R(r) and could not be further induced by cefoxitin (no
statistically significant).
For β-lactam resistance, as shown in Figure 4A, three levels
of AmpC hyper-production elevate the resistance capacity
to most penicillins, first-generation cephalosporins, third-
generation cephalosporins, monobactam, and cephamycins at
the three different levels. At the same time, MICs of imipenem,
meropenem, and ciprofloxacin were not changed. It should
be noted that no CLSI breakpoint was surpassed in any of
the antibiotics tested except for Ampicillin, Ticarcillin, and
Cephazolin which were native for resistance in Y. enterocolitica.
The complementation assays were performed introducing
pSRKTcD1, pSRKTcD2, and pSRKTcD3 into the triple-
mutant strain YE1D1D2D3. After quantifying the β-lactamase
activity of each complementary strain, as shown in Figure 4B,
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YE1D1D2D3 (pSRKTcD1) and YE1D1D2D3 (pSRKTcD2)
completely restored the β-lactamase activity to the level of
the wild-type strain YE105.5R(r); while in YE1D1D2D3
(pSRKTcD3), the β-lactamase activity significantly decreased,
but not reaching the level of wild-type strain (p< 0.05).
DISSCUSSION
The biological function of AmpD was first characterized in
E. cloacae and C. freundii (Lindberg et al., 1987; Peter et al.,
1988) where it played an essential role in suppressing the
ampC expression through the ampR-ampC system indirectly
and later studies on AmpD in other Gram-negative organisms
taken Enterbacteraceae as the paradigm (Juan et al., 2006; Yang
et al., 2009). However, each Enterobacteriaceae members usually
have peculiar features in AmpC regulation (Jacoby, 2009). In
E. coli, AmpC production was not inducible because having
no AmpR, and it was regulated by a promoter and attenuator
mechanism (Jaurin et al., 1981). In addition, expression of
ampC in Acinetobacter baumannii was also not inducible lacking
AmpR (Bou and Martinez-Beltran, 2000). As a member of
Enterobacteriaceae, Y. enterocolitica is not well-understood in
the features of ampC regulation. To date, a three-step ampC
regulation mechanism driven by three ampD homologs was only
observed in P. aeruginosa (Juan et al., 2006), while two AmpD
homologs were also identified in Stenotrophomonas maltophilia
but only AmpDI was effective in β-lactamase regulation (Yang
et al., 2009; Talfan et al., 2013).
In this study, we first reported the role of AmpD in
Y. enterocolitica and there has three AmpD homologs with
different features termed in AmpD1, AmpD2, and AmpD3 that
coordinate to repress the expression of ampC β-lactamase. As
shown in Figure 3, inactivation of ampD1 (YE1D1) results in an
obvious increased in basal and inducible levels compared to the
wild type (WT) strain, and a higher basal and inducible level was
achieved in ampD1–ampD2 double mutant strain (YE1D1D2).
However, although individual AmpD3 was ineffective (elevate
the value but no statistical significance), the ampD1–ampD3
double deletion strain YE1D1D3 caused a significant increase
from the basal expression level of ampC and cannot be further
induced by imipemem. The full derepression phenotype was
achieved in YE1D1D3, suggesting a synergetic effect between
AmpD1 and AmpD3. Finally, at the last level, triple mutants
strain YE1D1D2D3 was as same as YE1D1D3, achieving the full
derepression phenotype.
This three-step regulation mechanism has similarity with
the stepwise regulation mechanism in P. aeruginosa with a
few differences (Juan et al., 2006). In P. aeruginosa, over-
expression of each of the three AmpD homologs can return the
TABLE 3 | MICs of antibiotics for strain 105.5R(r) and ampD mutants.
Antibiotic MIC (mg/ml) of antibiotic of straina,b
YE105.5R(r) YE1D1 YE1D2 YE1D3 YE1D1D2 YE1D2D3 YE1D1D2D3 YE1D1D2D3
PENICILLINS
AMP 32 32 32 32 32 64 32 64
TIC 1 4 2 1 4 4 2 4
PIP 2 16 4 2 16 16 4 16
SAM 16 16 16 16 16 16 16 16
TZP 1 4 2 1 4 4 2 4
CEPHALOSPORINS
CFZ 128 512 128 256 512 512 256 512
CAZ 0.25 1 0.5 0.25 1 2 0.25 2
FEP 0.25 0.25 0.25 0.25 0.25 0.25 0.25 0.25
CRO ≤0.125 0.25 0.25 0.25 0.5 0.5 0.25 0.5
MONOBACTAM
ATM ≤0.125 0.5 ≤0.125 ≤0.125 0.5 1 0.25 1
CEPHAMYCINS
CTT 2 4 2 2 4 4 4 4
FOX 8 8 8 8 8 8 8 8
CARBAPENEMS
IPM 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5
MEM 0.25 0.25 0.25 0.25 0.25 0.25 0.25 0.25
QUINOLONES
CIP ≤0.03 ≤0.03 ≤0.03 ≤0.03 ≤0.03 ≤0.03 ≤0.03 ≤0.03
aAMP, Ampicillin; TIC, Ticarcillin; PIP, Piperacillin; SAM, Ampicillin-sulbactam; TZP, Piperacillin-tazobactam; CFZ, Cefazolin; CAZ, Ceftazidime; FEP, Cefepime; CRO, Ceftriaxone; ATM,
Aztreonam; CTT, Cefotetan; FOX, Cefoxitin; IPM, Imipenem; MEM, Meropenem; CIP, Ciprofloxacin.
bMIC was determined in triplicate by standard two-fold serial broth microdilution method, all measurements were performed in triplicate.
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high-level expression back to wild-type strain levels, suggesting
the three ampD homologs involved are repressing the ampC
expression quantitatively rather than qualitatively. However,
in Y. enterocolitica, after introducing recombinant expression
vector pSRKTcD1 and pSRKTcD2 (high expression AmpD1 and
AmpD2, respectively) to YE1D1D2D3, the high β-lactamase
activity was reduced to the low wild-type strain level. Compared
with AmpD1 and AmpD2, solely AmpD3 did not possess the
full capacity to repress the ampC expression. After introducing
pSRKTcD3 (high expression AmpD3) into YE1D1D2D3, the β-
lactamase activity is a limited reduction, not returning to the
level of the wild-type strain. Further, in P. aeruginosa, PA1DDh3
shows a high-level hyper-inducible expression state not observed
in Y. enterocolitica.
As shown in Table 3, the ampD mutant strains was maximal
quadrupling the MIC-values on TIC, PIP, TZP, CFZ, CAZ,
ATM but there is no CLSI breakpoint was surpassed in any
of the antibiotics tested in this experiment. This consequence
might seem like lack of clinical significance on the surface, but
actually, ampC-ampR system may participate in many aspect
of bacterial metabolization, as AmpR is a global transcriptional
factor in β-lactamases, proteases, quorum sensing, virulence
factors, and even iron acquisition (Balasubramanian et al., 2014;
Caille et al., 2014). AmpD was also at the crossroads in cell-wall
recycling and AmpC regulation simultaneously (Lee et al., 2009).
Three AmpD homologs cooperated with each other in cell-wall
recycling system results in a stabilized and efficient process to
recycle the useless peptidoglycan degradation products into cell
wall synthesis, so less energy will be needed in cell growth and
division. In survival in eukaryotes, extracellular muropeptides
can be recognized by the immune system, a potent cell-wall
recycling system ensures less muropeptides release results in
higher survival rates (Johnson et al., 2013). Moya et al. (2008)
found in competition experiments in the mouse model in vivo,
the ampD ampDh2 ampDh3 and ampC quadruple mutant P.
aeruginosa strain completely lost its biological competitiveness.
Recent studies demonstrate Y. enterocolitica strains of specific
biovars tend to display similar features in expression and the
activities of two different β-lactamases (Pham et al., 2000; Stock
et al., 2000; Sharma et al., 2006). Further studies are necessary to
understand the distribution and function of AmpD homologs in
each biovar of the Y. enterocolitica strains. Especially the AmpD3,
less effective alone, but has a potent synergetic effect together with
AmpD1. Furthermore, recent studies showed that penicillin-
binding protein 4 (DacB) affected the AmpC expression in
some bacteria (Zamorano et al., 2010), it will be attractive to
understand its function in Y. enterocolitica.
In summary, in the present study, we first illustrate the
role of AmpD in Y. enterocolitica and a three-step regulation
mechanism of ampC expression was found. Furthermore, this
was also the first report such complicated ampC regulation
mechanism appears in Enterobacteriaceae. It will be very
interesting to examine if this minority mechanism appears in
other Enterobacteriaceae family strains.
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